Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sage Therapeutics
Biotech
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Less than a year in, BenevolentAI CEO is out. Deshaies descends from Amgen research perch. Sage’s reorg scrambles executive team.
Darren Incorvaia
,
Zoey Becker
Oct 18, 2024 8:30am
Sage lays off half of R&D team, shakes up C-suite again
Oct 17, 2024 8:15am
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2
Oct 8, 2024 8:34am
Biogen cans SAGE-324 collaboration after essential tremor fail
Sep 26, 2024 9:00am
Biogen, Sage flunk midphase essential tremor trial, stop study
Jul 24, 2024 8:10am
Sage's dalzanemdor trial design leaves efficacy question unclear
Jun 11, 2024 8:28am
